Welcome Guest | Register / Login

Therapeutic Market Research Reports

Sort By
Title Published Price
Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Flexion Therapeutics Inc (Flexion) is a pharmaceutical company that develops and commercializes pain therapies. The company's products comprise FX006, FX007, and FX005. Its FX005 is a p38 mitogen-activated protein, kinase inhib...
Nov 2017 $ 300
D. Western Therapeutics Institute Inc (4576) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary D. Western Therapeutics Institute Inc (DWTI) is a pharmaceutical company that discovers and develops drugs for glaucoma. The company's product pipeline includes glanatek, K-134, H-1129 and H-1337. It develops drugs targeting di...
Nov 2017 $ 300
Intellia Therapeutics Inc (NTLA) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 system. The company develops in vivo programs for treating liver diseases such as t...
Nov 2017 $ 300
Cascadian Therapeutics Inc (CASC) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Cascadian Therapeutics Inc (Cascadian), formerly Oncothyreon Inc is a clinical-stage biotechnology company that develops therapeutic products for the treatment of cancer. The company's lead clinical-stage product candidate incl...
Nov 2017 $ 300
Crescita Therapeutics Inc (CTX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Crescita Therapeutics Inc (Crescita Therapeutics) develops products for the treatment of skin diseases and their symptoms. The company's product portfolio includes over-the-counter and prescription products such as topical crea...
Nov 2017 $ 300
DiaMedica Therapeutics Inc (DMA) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary DiaMedica Therapeutics Inc (DiaMedica), formerly DiaMedica Inc is a biopharmaceutical company that concentrates on recombinant proteins and monoclonal antibodies. The company's product portfolio includes DM199 acute ischemic st...
Nov 2017 $ 300
Factor Therapeutics Ltd (FTT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, which focuses on the development and commercialization of advanced wound care therapeutics. The company develops treatments for acute and chronic wound healing appli...
Nov 2017 $ 300
Inspyr Therapeutics Inc (GNSZ) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Inspyr Therapeutics Inc (Inspyr), formerly Genspera Inc is a biotechnology company that concentrates on the development of novel therapies for the treatment of cancer. The company is developing treatment in the areas including ...
Nov 2017 $ 300
Global Blood Therapeutics Inc (GBT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug can...
Nov 2017 $ 300
Sevion Therapeutics Inc (SVON) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Sevion Therapeutics Inc (Sevion), formerly Senesco Technologies, Inc. is a pharmaceutical company that discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company has ...
Nov 2017 $ 300
Knight Therapeutics Inc (GUD) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Knight Therapeutics Inc (Knight Therapeutics) is a pharmaceutical company that offers acquisition, in-licensing, selling and marketing of prescription, over the counter, and pharmaceutical products. The company's pipeline produ...
Nov 2017 $ 300
Pluristem Therapeutics Inc (PSTI) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Pluristem Therapeutics Inc (Pluristem) is a clinical-stage biotherapy company that develops cell therapies. The company's products pipeline includes PLX-PAD for multiple therapeutic indications and PLX -R18 for hematological in...
Nov 2017 $ 300
Bone Therapeutics SA (BOTHE) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Bone Therapeutics SA (Bone Therapeutics) is a bone cell therapy company that develops autologous and allogeneic cell therapy products for orthopedics and bone diseases. The company's product pipeline includes PREOB, an autologo...
Nov 2017 $ 300
Aimmune Therapeutics Inc (AIMT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Aimmune Therapeutics Inc (Aimmune), formerly Allergen Research Corp is a clinical-stage biopharmaceutical company that develops proprietary product candidates for the treatment of peanut and other food allergies. The company's ...
Nov 2017 $ 300
Argos Therapeutics Inc (ARGS) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Argos Therapeutics Inc (Argos) is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of infectious diseases and cancer. The company develops a pipeline of products based on its propri...
Nov 2017 $ 300
Audentes Therapeutics Inc (BOLD) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The company's pipeline products incl...
Nov 2017 $ 300
Cerenis Therapeutics Holding SA (CEREN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Cerenis Therapeutics Holding SA (Cerenis) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. The company is developing a portfolio of HDL therapi...
Nov 2017 $ 300
Edge Therapeutics Inc (EDGE) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes a range of hospital-based therapies. The company offers hospital based therapies capable of transfo...
Nov 2017 $ 300
Shield Therapeutics Plc (STX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals for high unmet medical needs. Its product port...
Nov 2017 $ 300
vTv Therapeutics Inc (VTVT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc is a clinical stage pharmaceutical company that discovers, develops and commercializes small molecule drug candidates. The company's pipeline products include azeliragon, TTP39...
Nov 2017 $ 300
Voyager Therapeutics Inc (VYGR) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Voyager Therapeutics Inc (Voyager) is a gene therapy company that develops treatments for fatal and debilitating diseases of the central nervous system. The company provides treatment for adeno-associated virus gene therapy fie...
Nov 2017 $ 300
Calmare Therapeutics Inc (CTTC) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Calmare Therapeutics Inc (CTI) is a biotherapeutic company that offers pain mitigation and wound care technologies. The company provides non-pharmacological, non-addictive and non-invasive solution for chronic neuropathic pain ...
Nov 2017 $ 300
VistaGen Therapeutics Inc (VTGN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary VistaGen Therapeutics Inc (VistaGen) is a clinical-stage biopharmaceutical company that offers drug development, rescue and discovery and regenerative medicine. The company provides human heart cells and liver cells by using it...
Nov 2017 $ 300
Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company's product candidate includes RT002, an injectable formulation of botulinum toxin type for the...
Nov 2017 $ 300
Prescient Therapeutics Ltd (PTX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cancers. The company's lead drug candi...
Nov 2017 $ 300